How to Buy Cellectis Sa Stock
Cellectis Sa
Cellectis S. A. , a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells.
Cellectis Sa stock last closed at $1.24, down 3.88% from the previous day, and has decreased 50.99% in one year. It has underperformed other stocks in the Biotechnology industry by 0.04 percentage points. Cellectis Sa stock is currently +8.77% from its 52-week low of $1.14, and -63.31% from its 52-week high of $3.38.
At the moment, there are 28M shares of CLLS outstanding. The market value of CLLS is $34.72M. In the last 24 hours, 13.87M CLLS shares were traded.
How to Buy Cellectis Sa Stock
Not sure how to invest in Cellectis Sa stock? Here's how.
- Choose where to buy Cellectis Sa stock: You need to choose an online brokerage, but don't worry - we've tested dozens of online stock brokerages and apps to help you determine where to buy Cellectis Sa stock.
- Open your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Deposit funds into your brokerage account: Select your payment method and add your information.
- Analyze Cellectis Sa stock: The Cellectis Sa ticker symbol is CLLS. Is Cellectis Sa stock a good investment? Should you buy shares of CLLS? How do CLLS's underlying business fundamentals look? Do top analysts think Cellectis Sa is a good buy? Why has CLLS's stock price moved recently? (Hint: Our stock research tools can help you understand if CLLS is a good stock to buy).
- Execute your CLLS trade: Decide if you will purchase CLLS shares at the current market price or use a limit order to buy CLLS stock at a specific price.
- Keep tabs on your CLLS investment: Create a watchlist to the latest updates on your position in Cellectis Sa stock.
Step 1: Choose where to buy Cellectis Sa stock
You will need a brokerage account in order to access the NASDAQ market and buy CLLS shares.
Our preferred brokerage: eToro
Based on our experience, eToro is the best stock brokerage. Here's why:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to world financial markets: From Technology to Financial Services, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading exchanges.
- Social investing: eToro boasts a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by opening an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Open your brokerage account
Now that you've selected the best brokerage, you'll need to fill out some personal information so you are able to invest in CLLS stock today.
How to Open a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal data to open a new trading account.
- Send your info by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you have filled out your info on the best stock app, your next step is to transfer the money for your investment:
Check out the walkthrough below to see the process of transferring money into your new investment account.
Step 4: Analyze Cellectis Sa stock
After you have identified the best place to buy Cellectis Sa stock, it's crucial to evaluate their stock prior to investing, so you truly wrap your head around the risk and upside.
Overview of key CLLS info
Cellectis Sa Due Diligence Checks
WallStreetZen was designed to help part-time investors perform more accurate fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on CLLS's stock page.
Is CLLS stock overvalued?
Investors use many financial metrics, analyses, models, and charts to gauge CLLS's intrinsic value.
Using relative valuations ratios:
- CLLS may be undervalued based on its P/B ratio of 0.26x, relative to Biotechnology industry P/B ratio of 4.68x
You can access additional valuation research on CLLS's stock here.
How do CLLS Financials look?
Passed Health Checks:
- There are more short-term assets than long-term liabilities on the CLLS balance sheet.
- CLLS's operating cash flow of $22.99M allows it to safely service it's debt of $109.65M.
- There are more short-term assets than short-term liabilities on the CLLS balance sheet.
Failed Health Checks:
- CLLS has a relatively high debt to equity ratio of 1.93.
- CLLS profit margin has gone up by 10.25 percentage points in the past year, but the company is still unprofitable.
- CLLS earnings of -$15.15M is not sufficient to cover its interest payments.
- Total CLLS debt is higher than 5 years ago, relative to shareholder equity.
Is it a good time to buy Cellectis Sa stock, according to analysts?
Out of 1 Wall Street analysts who give forecasts on CLLS, the consensus analyst rating on Cellectis Sa is a Strong Buy
Please note that analyst forecasts are not recommendations, nor are they financial advice.
You can dig deeper into what analysts are saying on the Cellectis Sa stock forecast page.
CLLS Trading Indicators
CLLS Revenue
Last year, CLLS revenue was $49.22M. During the last five year, CLLS's revenue has gone up by 16.44% per year. This was slower than the Biotechnology industry average of 44.6%.
Dig into CLLS's earnings and revenue performance here.
Who is buying/selling CLLS?
Over the last year, insiders at CLLS have not bought or sold any shares.
Dig into more about who owns CLLS stock here.
Can I rely on CLLS as an income stream?
No, Cellectis Sa doesn't provide an income stream by paying out dividends.
What others are saying about CLLS
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Execute your CLLS trade
There are two main types of orders:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are mostly fine for most investors. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to make sure you're buying or selling at a specific dollar amount, use a limit order.
Click the Open Trade button and eToro will execute your order.
If you want more info about buying stocks on eToro, watch the how to video below:
Step 6: Keep tabs on your CLLS investment
Now that you own some shares in CLLS, you'll want to keep up with your investment.
Create a watchlist to track the most important metrics related to your CLLS stock.
CLLS Feed
How to Buy Stock in Cellectis Sa
To summarize, here are the 6 steps for buying Cellectis Sa stock:
- Choose where to buy Cellectis Sa stock
- Open your brokerage account
- Deposit funds into your brokerage account
- Analyze Cellectis Sa stock
- Execute your CLLS trade
- Keep tabs on your CLLS investment
If you are looking for a brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you want to get updates on your investment in Cellectis Sa, click below.
More "How To" Guides You May Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.